141 related articles for article (PubMed ID: 15766561)
1. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
[TBL] [Abstract][Full Text] [Related]
2. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells.
Grunt TW; Tomek K; Wagner R; Puckmair K; Zielinski CC
Differentiation; 2007 Nov; 75(9):883-90. PubMed ID: 17608728
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways.
Grunt TW; Tomek K; Wagner R; Puckmair K; Kainz B; Rünzler D; Gaiger A; Köhler G; Zielinski CC
J Cell Physiol; 2007 Jun; 211(3):803-15. PubMed ID: 17286282
[TBL] [Abstract][Full Text] [Related]
4. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
5. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
6. [Methylation of promoter region of RAR-beta2 gene in renal cell, breast, and ovarian carcinomas].
Khodyrev DS; Loginov VI; Pronina IV; Kazubskaia TP; Gar'kavtseva RF; Braga EA
Genetika; 2008 Aug; 44(8):1126-32. PubMed ID: 18825962
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma.
Yang Q; Sakurai T; Yoshimura G; Mori I; Nakamura M; Nakamura Y; Suzuma T; Tamaki T; Umemura T; Kakudo K
Anticancer Res; 2001; 21(3B):1829-33. PubMed ID: 11497266
[TBL] [Abstract][Full Text] [Related]
8. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM
Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520
[TBL] [Abstract][Full Text] [Related]
9. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
10. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of human tumor cells to retinoids or combined treatment with retinoids and ionizing radiation is not dependent on RAR-beta 2 induction.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Strahlenther Onkol; 2003 Jun; 179(6):401-9. PubMed ID: 12789467
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
13. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
Liang ZD; Lippman SM; Wu TT; Lotan R; Xu XC
Cancer Res; 2006 Jul; 66(14):7111-8. PubMed ID: 16849557
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between RAR-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract][Full Text] [Related]
15. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
16. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.
Song S; Lippman SM; Zou Y; Ye X; Ajani JA; Xu XC
Oncogene; 2005 Dec; 24(56):8268-76. PubMed ID: 16170369
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
18. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
19. Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma.
Xu XC; Lee JJ; Wu TT; Hoque A; Ajani JA; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):826-9. PubMed ID: 15824151
[TBL] [Abstract][Full Text] [Related]
20. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
